Filing search / Centessa Pharmaceuticals plc / "Drug Pricing"

Search information

Centessa Pharmaceuticals plc

Companies

"Drug Pricing"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

18 results

Newest first Best match first

10-Q

2024 Q2

CNTA Centessa Pharmaceuticals plc

Quarterly report

with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted … federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under

13 Aug 24

7:27am

10-Q

2024 Q1

CNTA Centessa Pharmaceuticals plc

Quarterly report

to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal and state … legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review

13 May 24

4:32pm

10-K

2023 FY

CNTA Centessa Pharmaceuticals plc

Annual report

, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically … designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship

28 Mar 24

4:44pm

10-Q

2023 Q3

CNTA Centessa Pharmaceuticals plc

Quarterly report

order from President Biden that includes a proposed prescription drug pricing model that will test whether targeted Medicare payment adjustments … designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship

13 Nov 23

4:22pm

10-Q

2023 Q2

CNTA Centessa Pharmaceuticals plc

Quarterly report

that includes a proposed prescription drug pricing model that will test whether targeted Medicare payment adjustments will sufficiently incentivize … . There has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically

14 Aug 23

7:18am

10-Q

ij32fkw06194

Quarterly report

12 May 23

7:14am

10-K

ygvfoqfe g53zjkbo7

Annual report

30 Mar 23

7:44am

10-Q

hl4zi59ut7vvp7k6

Quarterly report

10 Nov 22

7:09am

10-Q

a0ns0ab58l7lzyf

Quarterly report

10 Aug 22

12:00am

10-Q

xgkem7owfxdy3m blvq

Quarterly report

16 May 22

7:41am

15 Nov 21

7:13am

Prospectus supplement with pricing info

4:07pm

S-1/A

vwrh5cvlywh

IPO registration (amended)

24 May 21

8:12am

S-1/A

u37n037o7p9l5udcg920

12 May 21

IPO registration (amended)

Draft registration statement

12:00am

Filing search / Centessa Pharmaceuticals plc / "Drug Pricing"

18 results

Top filers

Top filing types

Recent filing years